National Cancer Institute
Office of Technology and Industrial Relations

Contact Us  |  Site Map  |   

 

 

Skip Navigation

 

About OTIR Programs Funding Related Research Resources News & Events

 

Skip Navigation

 

About OTIR Programs Funding Related Research Resources News & Events

 


Office of Biorepositories and Biospecimen Research (OBBR)

Established: 2005

The NCI Office of Biorepositories and Biospecimen Research (OBBR) was established in recognition of the critical role that biospecimens play in cancer research. The OBBR will be responsible for developing a common biorepository infrastructure that promotes resource sharing and team science, in order to facilitate multi-institutional, high throughput genomic and proteomic studies. Carolyn Compton, M.D., Ph.D., serves as the Director of the OBBR.

The goals of the Office of Biorepositories and Biospecimen Research are to:

  • Establish biobanking as a new area of research, in order to determine the impact of various collection and processing protocols on the usefulness of biospecimens in genomic and proteomic studies
  • Disseminate First Generation Biorepository Guidelines in order to harmonize policies and procedures of NCI-supported biorepositories
  • Develop future generations of biorepository guidelines, based on the data generated in the biobanking research programs above
  • Promote professional oversight of biospecimen standards development by standards organizations
  • Develop new technologies for biorepository operations
  • Develop a biorepository accreditation program
  • Facilitate the establishment of a National Biospecimen Network
  • Coordinate with the international biobanking community to harmonize policies and procedures to facilitate multi-national research

To learn more about the Office of Biorepositories and Biospecimen Research, please visit http://biospecimens.cancer.gov.

Skip Navigation
National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthFirstGov.gov